Form 8-K - Current report:
SEC Accession No. 0000885590-23-000006
Filing Date
2023-02-23
Accepted
2023-02-23 07:10:42
Documents
14
Period of Report
2023-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20230223.htm   iXBRL 8-K 39173
2 EX-99.1 ex991-q4x2022.htm EX-99.1 731164
6 GRAPHIC image2.jpg GRAPHIC 7860
  Complete submission text file 0000885590-23-000006.txt   971833

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20230223.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20230223_lab.xml EX-101.LAB 25096
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20230223_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20230223_htm.xml XML 11484
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 23655906
SIC: 2834 Pharmaceutical Preparations